Incretin Mimetics

DBCAT003758Therapeutic category

Compounds that stimulate the activity of GLUCAGON-LIKE PEPTIDE-1 RECEPTOR. Glucagon-like peptide-1 receptor agonists are used to treat TYPE 2 DIABETES and OBESITY. A DrugBank category of 6 drugs. 6 of them are approved.

Drugs: Albiglutide
Dulaglutide
Exenatide
Liraglutide
Lixisenatide
Semaglutide

What you can answer from here — as of October 27, 2017

6DrugsEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

491Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Incretin Mimetics share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account